1-Propanethiol, 3-(diMethylaMino)-, hydrochloride

  Cat. No.:  DC67312   Featured
Chemical Structure
38048-81-6
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Cas No.: 38048-81-6
Chemical Name: 1-Propanethiol, 3-(dimethylamino)-, hydrochloride
Synonyms: 1-Propanethiol, 3-(dimethylamino)-, hydrochloride;3-(Dimethylamino)-1-propanethiol hydrochloride;3-(dimethylamino)propane-1-thiol hydrochloride;DTXSID10971151;55778-17-1;3-(dimethylamino)propanethiol hydrochloride;38048-81-6;3-(Dimethylamino)propane-1-thiol hydrochloride;MFCD00054635;AKOS028113818;EN300-6754258;SCHEMBL6057729;3-(dimethylamino)propane-1-thiol;hydrochloride;3-(Dimethylamino)propane-1-thiol--hydrogen chloride (1/1);Dimethyl(3-mercaptopropyl)ammonium chloride;GEO-03245;EINECS 259-815-7
SMILES: CN(C)CCCS.Cl
Formula: C5H13NS.HCl
M.Wt: 155.689
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
Cat. No. Product name Field of application
DC67313 6-Oxohexyl 2-hexyldecanoate
DC67312 1-Propanethiol, 3-(diMethylaMino)-, hydrochloride
DC67311 1-Propanaminium, 2,3-dihydroxy-N,N,N-trimethyl-, chloride (1:1), (2R)-
DC67310 1,4-Piperazinediethylamine
DC67309 H2N(CH2)3N(tert-butoxycarbonyl)(CH2)4NH2
DC67308 CbzNH-PEG1-Br
DC67307 1-Piperazineethanamine, N-(phenylmethyl)-
DC67306 1-Propanethiol, 3-(dimethylamino)-, 4-methylbenzenesulfonate (1:1)
DC60798 6-[1-(Hexyloxy)ethoxy]hexanal(MK16 tail) 6-[1-(Hexyloxy)ethoxy]hexanal is the tail fragement for MK16.MK16 is a novel blood-brain barrier (BBB)-crossing lipid nanoparticle (BLNP) platform developed for efficient mRNA delivery to the central nervous system (CNS).
DC67297 SM6.1 (αvβ6 ligand) SM-6.1 is a small molecule delivery vehicle developed by Arrowhead, targeting αvβ6, which selectively delivers therapeutic siRNA to lung epithelial cells and mediates durable gene silencing post-inhalation.
X